Hemochromatosis, iron toxicity and disease

Journal of Internal Medicine

Volumn 268, Issue 3, 2010, Pages 246-248

  Zacharski, L R ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRCA2 PROTEIN; FERROPORTIN; HEME; HEPCIDIN; TRANSFERRIN;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; EDITORIAL; ESSENTIAL HYPERTENSION; FEEDBACK SYSTEM; FOAM CELL; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEART ARRHYTHMIA; HEART DILATATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; IRON DEPLETION; IRON OVERLOAD; IRON TRANSPORT; LIPID OXIDATION; MACROPHAGE; MENSTRUATION; OXIDATIVE STRESS; PHLEBOTOMY; PRIORITY JOURNAL; STROKE; TRANSFERRIN BLOOD LEVEL;

AGE FACTORS; FEMALE; HEMOCHROMATOSIS; HUMANS; HYPERTENSION; IRON OVERLOAD; MALE;

EID: 77955264378     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02233.x     Document Type: Editorial

References (20)

1. Ellervik C, Tybjaerg-Hansen A, Appleyard M, Ibsen H, Nordestgaard B. Hemochromatosis genotype, iron overload, hypertension, and left ventricular hypertrophy. J Intern Med 2010 268 : 252 264.
2. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 2005 68 : 26 36.
3. Piperno A, Trombini P, Gelosa M et al. Increased serum ferritin is common in men with essential hypertension. J Hypertens 2002 20 : 1513 1518.
4. Failla M, Giannattasio C, Piperno A et al. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 2000 32 : 569 573.
5. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM. The association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000 40 : 98 104.
6. Lee DH, Zacharski LR, Jacobs DR Jr. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes. Am Heart J 2006 15 : 1247.
7. Subash P, Premagurumurthy K, Sarasabharathi A, Cherian KM. Total antioxidant status and oxidative DNA damage in a South Indian population of essential hypertensives. J Hum Hypertens 2010 24 : 475 482.
8. de la Sierra A, Larrousse M. Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension. J Hum Hypertens 2009. [Epub ahead of print].
9. Basu A, Penugonda K. Pomegranate juice: a heart-healthy fruit juice. Nutr Rev 2009 67 : 49 56.
10. Tzoulaki I, Brown IJ, Chan Q et al. International Collaborative Research Group on Macro-/Micronutrients and Blood Pressure. Relation of iron and red meat intake to blood pressure: cross sectional epidemiological study. BMJ 2008 337 : a258. DOI:.
11. Barton JC, Edwards CQ, eds. Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment. Cambridge, UK : Cambridge University Press, 2000 600 pp.
12. Solanas-Barca M, Mateo-Gallego R, Calmarza P et al. Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia. J Clin Endocrinol Metab 2009 94 : 4391 4397. Epub October 9.
13. Zacharski LR, Chow BK, Howes PS et al. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease. JAMA 2007 297 : 603 610.
14. Sullivan JL. Do hemochromatosis mutations protect against iron-mediated atherogenesis? Circ Cardiovasc Genet 2009 2 : 652 657.
15. Syrjakoski K, Fredriksson H, Ikonen T et al. Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients. Int J Cancer 2006 118 : 518 520.
16. Hong CC, Ambrosone CB, Ahn J et al. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2007 16 : 1784 1794. Epub August 28.
17. Chitambar CR, Kotamraju S, Wereley JP. Expression of the hemochromatosis gene modulates the cytotoxicity of doxorubicin in breast cancer cells. Int J Cancer 2006 119 : 2200 2204.
18. Zacharski LR, Chow BK, Howes PS et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 2008 100 : 996 1002. Epub 2008 July 8.
19. Zacharski LR, McKernan LJ, Metzger ME et al. Remission of paroxysmal atrial fibrillation with iron reduction in hemophilia A. Blood 2009 114. November 20, abst 5100. Available at: http://abstracts.hematologylibrary.org/ cgi/content/abstract/114/22/5100?maxtoshow=& hits=10&RESULTFORMAT= &fulltext=5100&searchid=1&FIRSTINDEX=0&sortspec= relevance&resourcetype=HWCIT.
20. Buijsse B, Feskens EJ, Moschandreas J et al. Oxidative stress, and iron and antioxidant status in elderly men: differences between the Mediterranean south (Crete) and northern Europe (Zutphen). Eur J Cardiovasc Prev Rehabil 2007 14 : 495 500.